Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

Clinical trial NCT01348555 · COMPLETED

Trial details

NCT number: NCT01348555
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2011-04-01
Primary completion: 2012-07-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.